Skip to content
MedsAcross

Medicine

Entecavir 1 mg tablet

Entecavir · Oral
Available on requestPrescription onlyUS FDAGeneric name

Entecavir 1 mg tablet is a generic prescription medicine for oral use, made by 10 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Entecavir tablets should be stored in a tightly closed container between 20°C…

Key facts

Active ingredient (INN)
Entecavir
Brand
Sold under the generic name
Strength
1 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 30 tablets, 90 tablets and 22 more
Manufacturers
Zydus LifesciencesIndiaCamber PharmaceuticalsIndiaAurobindo PharmaIndiaCiplaIndiaSolco HealthcareEpic PharmaAmneal PharmaceuticalsCameron PharmaceuticalsNorthStar RxLLCYaopharma
Origin register
US FDA, United States
Storage
Entecavir tablets should be stored in a tightly closed container between 20°C and 25°C (68°F and 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
J05AF10 Entecavir
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
28 November 2014
Identifiers
RxCUI 485434, 485436DailyMed set ID bb1bb6dc-0120-46e2-ad1e-d9afc221fa16, da705339-c349-444f-a058-4f0cef2864bf, 01ec50a1-6c6c-46f0-8c74-73542b0a59c3 +9NDC 43547-437, 16714-718, 31722-834 +9Application ANDA208782, ANDA206872, ANDA205740 +6

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet, film coated in 1 bottle68382-921-01Zydus LifesciencesIndia10 August 2017
30 tablet, film coated in 1 bottle68382-921-06Zydus LifesciencesIndia10 August 2017
90 tablet, film coated in 1 bottle68382-921-16Zydus LifesciencesIndia10 August 2017
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack68382-921-77Zydus LifesciencesIndia10 August 2017
100 tablet, film coated in 1 bottle70771-1020-1Zydus LifesciencesIndia10 August 2017
30 tablet, film coated in 1 bottle70771-1020-3Zydus LifesciencesIndia10 August 2017
10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack70771-1020-4Zydus LifesciencesIndia10 August 2017
90 tablet, film coated in 1 bottle70771-1020-9Zydus LifesciencesIndia10 August 2017
1 bottle in 1 carton / 30 tablet in 1 bottle65862-842-30Aurobindo PharmaIndia26 August 2015
1 bottle in 1 carton / 90 tablet in 1 bottle65862-842-90Aurobindo PharmaIndia26 August 2015
1 bottle in 1 carton / 1000 tablet in 1 bottle65862-842-99Aurobindo PharmaIndia26 August 2015
30 tablet in 1 bottle31722-834-30Camber PharmaceuticalsIndia21 August 2015
10 tablet in 1 blister pack31722-834-31Camber PharmaceuticalsIndia21 August 2015
100 tablet in 1 carton31722-834-32Camber PharmaceuticalsIndia21 August 2015
90 tablet in 1 bottle31722-834-90Camber PharmaceuticalsIndia21 August 2015
30 tablet, film coated in 1 bottle, plastic69097-425-02CiplaIndia6 December 2016
30 tablet in 1 bottle, plastic42806-659-30Epic Pharma2 June 2020
1 bottle in 1 carton / 30 tablet, film coated in 1 bottle42806-668-30Epic Pharma1 November 2022
30 tablet, film coated in 1 bottle65162-449-03Amneal Pharmaceuticals28 November 2014
30 tablet in 1 bottle42494-458-30Cameron Pharmaceuticals15 May 2025
30 tablet, film coated in 1 bottle43547-437-03Solco Healthcare1 April 2018
90 tablet, film coated in 1 bottle43547-437-09Solco Healthcare1 April 2018
500 tablet, film coated in 1 bottle43547-437-50Solco Healthcare1 April 2018
30 tablet, film coated in 1 bottle50771-014-01Yaopharma1 July 2023
30 tablet, film coated in 1 bottle, plastic16714-718-01NorthStar RxLLC15 June 2017

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 29 March 2005Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Entecavir 1 mg tablet.

Compare 1

Other strengths and forms of Entecavir

Clinical summary

Entecavir is a hepatitis B virus nucleoside analog reverse transcriptase inhibitor indicated for the treatment of chronic hepatitis B virus infection in adults, among other approved uses. It is available as tablets and oral solution. MedsAcross supplies Entecavir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Entecavir

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Entecavir 1 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.